At a glance
ClinicalIndex Comparison RecordN/ACompleted· 54 enrolled
Drug / intervention
Beating the Bluesbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Controlled Pilot Trial Assessing the Utility of Cognitive Behavioral Therapy to Improve Endothelial Function and Reduce Inflammation in Depressed, Virologically-Suppressed, Antiretroviral-Treated, HIV-infected Adults
In Brief
A clinical study evaluating Beating the Blues for Depression and HIV. Completed, enrolled 54 participants across 2 sites.
Detailed Summary
This trial will determine if depression treatment will reduce cardiovascular risk in HIV-infected patients already receiving HIV treatments. Half of the participants will undergo a specific computerized depression treatment with the other half receiving usual care from their HIV providers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression, HIV
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 2014
Enrollment StartApr 2015
Primary CompletionApr 2019
TodayJul 2026
First PostedDec 5, 2014
Enrollment StartApr 1, 2015
Primary CompletionApr 1, 2019
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 11.6 years ago
Interventions
Beating the Bluesbehavioral
Computerized depression treatment intervention